JMJD3 and vascular injury: the Emperor's new clothes

被引：1

作者：

Mongelli, Alessia ^{[1
]}

Gaetano, Carlo ^{[1
]}

机构：

[1] Ist Clin Sci Maugeri, Lab Epigenet, Via Maugeri 4, Pavia, Italy

来源：

CARDIOVASCULAR RESEARCH | 2018年 / 114卷 / 14期

关键词：

DIFFERENTIATION; DEMETHYLASES;

D O I：

10.1093/cvr/cvy249

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1825 / 1827

页数：3

共 50 条

[41] Jmjd3 Plays Pivotal Roles in the Proper Development of Early-Born Retinal Lineages: Amacrine, Horizontal, and Retinal Ganglion Cells [J].

Iwagawa, Toshiro ;

Honda, Hiroaki ;

Watanabe, Sumiko .

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (11)

[42] MUSASHI-Mediated Expression of JMJD3, a H3K27me3 Demethylase, Is Involved in Foamy Macrophage Generation during Mycobacterial Infection [J].

Holla, Sahana ;

Prakhar, Praveen ;

Singh, Vikas ;

Karnam, Anupama ;

Mukherjee, Tanushree ;

Mahadik, Kasturi ;

Parikh, Pankti ;

Singh, Amit ;

Rajmani, R. S. ;

Ramachandra, Subbaraya G. ;

Balaji, Kithiganahalli Narayanaswamy .

PLOS PATHOGENS, 2016, 12 (08)

[43] Targeting Esophageal Squamous Cell Carcinoma by Combining Copper Ionophore Disulfiram and JMJD3/UTX Inhibitor GSK J4 [J].

Yang, Canlin ;

Li, Fei ;

Ren, Yuanyuan ;

Zhang, Qianqian ;

Jiao, Bo ;

Zhang, Jianming ;

Huang, Junxing .

CANCERS, 2023, 15 (22)

[44] H3K27 Methylation Dynamics during CD4 T Cell Activation: Regulation of JAK/STAT and IL12RB2 Expression by JMJD3 [J].

LaMere, Sarah A. ;

Thompson, Ryan C. ;

Meng, Xiangzhi ;

Komori, H. Kiyomi ;

Mark, Adam ;

Salomon, Daniel R. .

JOURNAL OF IMMUNOLOGY, 2017, 199 (09) :3158-3175

[45] The Role of NF-κB and H3K27me3 Demethylase, Jmjd3, on the Anthrax Lethal Toxin Tolerance of RAW 264.7 Cells [J].

Das, Nando Dulal ;

Jung, Kyoung Hwa ;

Chai, Young Gyu .

PLOS ONE, 2010, 5 (03)

[46] Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia [J].

Li, Yunan ;

Zhang, Mingying ;

Sheng, Mengyao ;

Zhang, Peng ;

Chen, Zizhen ;

Xing, Wen ;

Bai, Jie ;

Cheng, Tao ;

Yang, Feng-Chun ;

Zhou, Yuan .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (06) :1065-1077

[47] JMJD3 promotes the epithelial-mesenchymal transition and migration of glioma cells via the CXCL12/CXCR4 axis [J].

Zou, Shuang ;

Zhang, Dongchen ;

Xu, Zhongwei ;

Wen, Xiaochang ;

Zhang, Yan .

ONCOLOGY LETTERS, 2019, 18 (06) :5930-5940

[48] JMJD3 suppresses stem cell-like characteristics in breast cancer cells by downregulation of Oct4 independently of its demethylase activity [J].

Xun, Jing ;

Wang, Dekun ;

Shen, Long ;

Gong, Junbo ;

Gao, Ruifang ;

Du, Lingfang ;

Chang, Antao ;

Song, Xiangrong ;

Xiang, Rong ;

Tan, Xiaoyue .

ONCOTARGET, 2017, 8 (13) :21918-21929

[49] H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis [J].

Park, Woo-Yong ;

Hong, Beom-Jin ;

Lee, Jungsul ;

Choi, Chulhee ;

Kim, Mi-Young .

CANCER RESEARCH, 2016, 76 (01) :161-170

[50] Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+cells [J].

Wei, Y. ;

Chen, R. ;

Dimicoli, S. ;

Bueso-Ramos, C. ;

Neuberg, D. ;

Pierce, S. ;

Wang, H. ;

Yang, H. ;

Jia, Y. ;

Zheng, H. ;

Fang, Z. ;

Nguyen, M. ;

Ganan-Gomez, I. ;

Ebert, B. ;

Levine, R. ;

Kantarjian, H. ;

Garcia-Manero, G. .

LEUKEMIA, 2013, 27 (11) :2177-2186

← 1 2 3 4 5 →